Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

for
Recurrent or Metastatic Solid Tumors
Location: Westbury NY, White Plains NY, New York NY, Fairfax VA,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06330064

Phase 1, Phase 2, Recruiting

Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines

for
Cardiotoxicity, Heart Failure, Breast Cancer,
Location: Stony Brook NY
Sponsor: Stony Brook University

Sex: Female

Age: 18 - 70+

Code: NCT03155802

Recruiting

Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia

for
Malignant Solid Tumors
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06629584

Phase 2, Recruiting

Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors.

for
Advanced Solid Tumor
Location: Boston MA
Sponsor: Oncomatryx Biopharma S.L.

Sex: All

Age: 18+

Code: NCT05547321

Phase 1, Recruiting

Hyper-Personalized Medicine Using Patient Derived Xenografts (PDXovo) for Metastatic Solid Tumors

for
Kidney Neoplasm, Carcinoma, Renal Cell, Metastatic Solid Tumor
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: All

Age: 18+

Code: NCT04602702

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

for
Cancer, Cancer Risk
Location: Albuquerque NM
Sponsor: New Mexico Cancer Research Alliance

Sex: All

Age: 18+

Code: NCT03977402

Recruiting

Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies

for
Solid Tumor
Location: Columbus OH, West Valley City UT
Sponsor: Jabez Bioscience, Inc

Sex: All

Age: 18+

Code: NCT06801002

Phase 1, Recruiting

Impact of the Coronavirus (COVID-19) on Patients With Cancer

for
Cancer, COVID-19
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 18 - 70+

Code: NCT04330521

Recruiting

Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer

for
Metastatic Breast Cancer
Location: Louisville KY
Sponsor: University of Louisville

Sex: Female

Age: 18+

Code: NCT04990921

Phase 2, Recruiting

Couplelinks.ca - An Online Intervention for Couples Affected by Breast Cancer

for
Distress, Breast Cancer, Depression, Anxiety
Location: Halifax, Toronto, Winnipeg, Vancouver
Sponsor: Canadian Breast Cancer Research Alliance

Sex: All

Age: 18 - 53

Code: NCT01089764

Phase 3, Recruiting

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

for
Cardiac Toxicity, Early-stage Breast Cancer
Location: Long Branch NJ, Jersey City NJ, Lakewood NJ,
Sponsor: Rutgers, The State University of New Jersey

Sex: Female

Age: 18+

Code: NCT05559164

Phase 2, Recruiting

Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer

for
Metastatic Breast Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: Female

Age: 18+

Code: NCT06409390

Phase 2, Recruiting

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Chapel Hill NC, St Louis MO, Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06179303

Phase 2, Recruiting

SNV1521 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Haven CT, Philadelphia PA, Toronto, Nashville TN,
Sponsor: Synnovation Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06220864

Phase 1, Recruiting

Patient-Derived Xenografts to Reduce Cancer Health Disparities

for
Bladder Carcinoma, Gastric Carcinoma,
Location: Orange CA, Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 21 - 70+

Code: NCT04410302

Recruiting

Psilocybin Therapy in Advanced Cancer

for
Advanced Cancer
Location: New York NY, Aurora CO
Sponsor: NYU Langone Health

Sex: All

Age: 21 - 70+

Code: NCT05398484

Phase 2, Phase 3, Recruiting

Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer

for
Pediatric Cancer
Location: Wilmington DE
Sponsor: Nemours Children's Clinic

Sex: All

Age: 0+

Code: NCT05294302

Recruiting

Postoperative Outcomes and Patient Satisfaction With Mayo Clinic Florida Care Hotel After Mastectomy and Tissue Expander Placement

for
Breast Carcinoma
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: Female

Age: 18+

Code: NCT06783179

Recruiting

An Observational Study On TheAccuracy Of Whole-Body Magnetic Resonance Imaging (Wb-Mri) ScreeningTo Predict Clinically Significant Diagnoses In General Population Subjects Interested In Proactive And Advanced General Preventive Healthcare.

for
Cancer, Metabolic Disease, Aneurysm, Neurologic Disorder
Location: Watertown MA
Sponsor: Hercules

Sex: All

Age: 18+

Code: NCT06212479

Recruiting

Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis

for
Cancer, Pancreatic Cancer
Location: Vancouver
Sponsor: British Columbia Cancer Agency

Sex: All

Age: 18+

Code: NCT02869802

Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial